Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
This piece walks through why forks occur in blockchains, from protocol changes to governance decisions, with real-world examples to illustrate the process.
18,016 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Rhythmic secures a $4 million seed round led by Dragonfly to embed stablecoins into consumer-brand ecosystems, pairin...
Visa extends its four-year partnership with Red Bull Racing, expanding branding and fan experiences amid lingering qu...
Insider moves can tell us a lot about a stock’s near-term path. When Intuitive Machines’ CEO disclosed a $1.39 millio...
Headline drama can ripple through your finances. Learn practical steps to stay focused, protect your investments, and...
Stocks wiggle as CoreWeave drops on news of Blue Owl’s failed $4B debt placement. Experts say the financing hiccup co...
Three ETF filings aim to convert binary election outcomes into tradable funds, moving political bets from niche marke...
Tilray’s stock has been a rollercoaster, but deciding whether to time dump your shares depends on your portfolio, ris...
A seasoned financial planner argues that a two-ETF approach can cover most retirement needs, pairing a dividend-based...
Industry chatter points to a late-2026 filing for a BlackRock XRP ETF, contingent on liquidity and demand. Six XRP ET...
Investing in Nexpoint Residential (NXRT) hinges on understanding earnings beyond headline numbers. This guide breaks ...
Nvidia's next earnings report may hinge on a single, less-obvious metric. This article explains what that figure is, ...